Beyond the Qubit podcast

The Cryo-CMOS Race May Be Decided Before 2030

0:00
1:16:33
15 Sekunden vorwärts
15 Sekunden vorwärts

The cryo-CMOS market may still look early. But the leaders may already be starting to emerge.


In this episode, I explore my biggest takeaways from my Beyond the Qubit interview with Eric W. Cao, Co-Founder and CEO of Qifrost. Eric believes the scaling bottleneck that cryo-CMOS aims to solve could become critical around 2030, give or take a couple of years. But companies cannot wait until then to prepare. The next 24 months could be when the leaders begin to separate themselves from the rest of the market.


This episode is for investors, founders, and anyone trying to understand where value may emerge in the quantum hardware supply chain. Cryo-CMOS aims to address the scaling challenges of controlling quantum processors at cryogenic temperatures. But laboratory validation is only the first step. The next challenge is proving that the technology works inside commercial quantum processing units, alongside real architectures and roadmaps.


That is what makes Qifrost interesting. The progression is clear: laboratory validation, commercial validation, standardization, and eventually mass manufacturing. The race may not be won by the company with the most impressive laboratory demonstration, but by the one that integrates its technology with commercial quantum hardware first.


💡 In this episode, we cover:

  • Why cryo-CMOS could become a critical quantum scaling technology

  • Why the next 24 months may help determine the market leaders

  • How cryogenic control electronics could reduce wiring complexity

  • Why laboratory validation is no longer enough

  • How commercial validation differs from proving technology in the lab

  • Why co-development with quantum processor companies matters

  • How standardization and mass manufacturing fit into the roadmap

  • What investors should watch as Qifrost moves toward commercial adoption


Chapters

00:00 Why Qifrost matters for quantum investors

01:00 Why existing quantum control infrastructure will not scale

02:30 Why the next 24 months matter for cryo-CMOS

04:30 From laboratory validation to commercial validation

11:00 The physical scaling bottleneck in quantum hardware

36:30 Why cryo-CMOS is a strategic opportunity

43:00 Why commercial execution matters more than the technology alone

65:30 Building relationships with quantum hardware developers

72:30 What it takes to prove cryo-CMOS commercially


Share this episode with someone investing in or building in quantum, and subscribe or follow Beyond the Qubit for more conversations on quantum technology, markets, and investing.


📌 Disclaimer:This is not investment advice.This post is shared on a personal basis and I do not represent any company.


Weitere Episoden von „Beyond the Qubit“